logo
  

Ball Corp. Aims To Achieve Net Zero Carbon Emissions Before 2050

Ball Corp. (BLL) commits to achieving net zero carbon emissions before 2050 and transitioning to 100% renewable electricity by 2030.

The goals also include ensuring all aluminum is purchased from certified sustainable sources and converting 80% of Ball's global beverage can volumes to its lightweight STARcan designs.

Ball said it is expanding its disclosure of existing D&I and social programs with specific 2025 goals for every region and business. Ball Beverage Packaging South America has committed to increasing the proportion of non-white employees in new hires from 31% to 47%, and Ball Beverage Packaging EMEA plans to increase representation of women in manufacturing roles by achieving a 25% recruitment rate of women for these positions.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's Cyltezo as the first interchangeable biosimilar to AbbVie's top-selling drug Humira or adalimumab. Cyltezo, originally approved in August 2017, is both biosimilar to, and interchangeable with Humira for Cyltezo's approved uses. The Food and Drug Administration may be planning to allow people to receive Covid-19 vaccine booster shot that is different from the initial dose, reports indicate. The agency is likely to make the announcement on mix and match approach on coronavirus booster vaccines on Wednesday. The move will be part of FDA's expected authorization of boosters for the Moderna and Johnson & Johnson vaccines. Drug major Johnson & Johnson on Tuesday raised again its forecast for fiscal 2021 earnings and sales, which are above market view, after reporting higher results in the third quarter. The company's quarterly adjusted earnings also beat market estimates. In pre-market activity on the NYSE, JNJ shares were gaining around 1.24 percent to trade at $162.10.
Follow RTT